 On
August 13th and 14th, 151 members of the quitline
community and our partners met in Kansas City, Missouri for the 2012 NAQC
Conference. Participants included U.S. and Canadian quitline researchers and
evaluators, funders, service providers and national partners. Conference sponsors and supporters included: ClearWay
Minnesota, Canadian Cancer Society, American Cancer Society, American Legacy
Foundation, GlaxoSmithKline, Novartis, Pfizer, and National Cancer Institute.
The
2012 theme, QUITLINE INNOVATION AND
SUSTAINABILITY: Exploring Strategies and Seizing Opportunities in Challenging
Times, builds on the Consortium’s efforts to contribute to the
understanding and measurement of quitline quality and the development of
emerging and innovative practices. The conference agenda focused solely on addressing
current challenges facing quitlines and tobacco cessation more broadly,
identifying strategies to address operational and implementation roadblocks and
the translation of recent research and evaluation findings into improved
strategies, practices and services.
Through
participation in 12 breakout sessions in 4 tracks, two luncheon plenaries,
opening and closing plenary sessions, NAQC’s Vision Cafe and ample
opportunities for sharing with and learning from colleagues, attendees:
- engaged in discussions with
colleagues and experts from the quitline community, as well as guests from
broader tobacco control and chronic disease areas, with a focus on factors that
impact on the effectiveness and reach of quitlines;
- developed concrete strategies for addressing changes in needs, funding, the political landscape and technologies that may transform quitline practice, protocols and our common research agenda;
- strengthened the quitline
community’s knowledge and application of best and promising practices;
- participated in the generation of
new research questions informed by dialogue about current experience from the
quitline practice community, findings from the research community and issues
important to partners in tobacco control, chronic diseases and health systems;
and
- celebrated 20 years of quitlines in North America and focus on answering important questions about the future of our work.
|
Print to Page
